Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends – 2012...市場調査レポートについてご紹介

【英文タイトル】Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Pharmaceutical & Healthcare, Global, Deals Summary 9
2.1 Pharmaceutical & Healthcare, Global, Deals Analysis, 2012 9
2.1.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, 2012 by Quarter 11
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, 2012 13
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, 2012 14
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, 2012 15
2.5 Pharmaceuticals & Healthcare, Top Deals, Global, Summaries, 2012 16
2.5.1 Abbott Completes Private Placement of Notes for $14.7 Billion 16
2.5.2 Nestle Completes Acquisition of Pfizer Nutrition from Pfizer for $11.85 Billion 16
2.5.3 Roche Revises Offer Price to Acquire Illumina for Up To $8.2 Billion 16
2.5.4 Aetna Receives Shareholders Approval to Acquire Coventry Health Care for $7.3 Billion 17
2.5.5 Walgreen Acquires 45% Stake in Alliance Boots from KKR And AXA Private Equity for $6.7 Billion 17
2.5.6 Watson Pharma Completes Acquisition of Actavis Group for $5.92 Billion 18
2.5.7 Bristol-Myers Squibb Completes Acquisition of Amylin Pharma for $5.3 Billion 19
2.5.8 GlaxoSmithKline Completes Public Offering of Notes for $5 Billion 19
2.5.9 UnitedHealth Completes Acquisition of 60% Stake in Amil Participacoes 19
2.5.10 WellPoint Completes Acquisition of Amerigroup for $4.9 Billion 20
3 Pharmaceuticals & Healthcare, Global, Top Deal Makers, 2012 21
4 Pharmaceuticals & Healthcare, Global, Deal Summary, by Type 22
4.1 Pharmaceuticals & Healthcare, Global, M&A, 2012 22
4.1.1 Pharmaceuticals & Healthcare, Global, M&A, 2012 by Quarter 23
4.1.2 Top M&A Deals in 2012 24
4.1.3 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, 2012 25
4.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2012 26
4.2.1 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, 2012 by Quarter 27
4.2.2 Pharmaceuticals & Healthcare, Global, IPO Deals, 2012 28
4.2.3 Pharmaceuticals & Healthcare, Global, Secondary Offerings Deals, 2012 30
4.2.4 Pharmaceuticals & Healthcare, Global, PIPE Deals, 2012 32
4.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, 2012 34
4.3 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, 2012 35
4.3.1 Pharmaceuticals & Healthcare, Global Debt Offerings, 2012 by Quarter 36
4.3.2 Pharmaceuticals & Healthcare, Global, Public Debt Offerings, 2012 37
4.3.3 Pharmaceuticals & Healthcare, Global, Private Debt Placements, 2012 38
4.3.4 Pharmaceuticals & Healthcare, Global, Debt Offering Deals, by Therapy Area, 2012 39
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2012 40
4.4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, 2012 by Quarter 41
4.4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, 2012 43
4.4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Value (US$ m), 2012 44
4.4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 45
4.4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, 2012 46
4.4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), 2012 47
4.4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 48
4.5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2012 51
4.5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, 2012 by Quarter 52
4.5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, 2012 53
4.5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Upfront & Milestone Payments and Deal Value (US$ m), 2012 54
4.5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 55
4.5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2012 56
4.5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), 2012 57
4.5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreements, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), 2012 58
4.6 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2012 61
4.6.1 Pharmaceuticals & Healthcare, Global, Private Equity Deals, 2012 by Quarter 62
4.6.2 Top Private Equity Deals in 2012 63
4.6.3 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, 2012 64
4.7 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, 2012 65
4.7.1 Pharmaceuticals & Healthcare, Global, Venture Financing Deals, 2012 by Quarter 66
4.7.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2012 67
4.7.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, 2012 68
4.7.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, 2012 69
4.7.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Last One Year 70
4.7.6 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, 2012 71
4.7.7 Top Venture Financing Deals in 2012 72
5 Pharmaceuticals & Healthcare, Global, Deal Summary, By Market 73
5.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2012 73
5.1.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, 2012 by Quarter 75
5.1.2 Oncology – Deals of the Year 76
5.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2012 78
5.2.1 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, 2012 by Quarter 79
5.2.2 Central Nervous System – Deals of the Year 80
5.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2012 82
5.3.1 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, 2012 by Quarter 83
5.3.2 Infectious Disease – Deals of the Year 84
5.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2012 86
5.4.1 Pharmaceuticals & Healthcare, Global, Immunology Deals, 2012 by Quarter 87
5.4.2 Immunology – Deals of the Year 88
5.5 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2012 90
5.5.1 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, 2012 by Quarter 91
5.5.2 Cardiovascular – Deals of the Year 92
5.6 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2012 93
5.6.1 Pharmaceuticals & Healthcare, Global, Metabolic Disorders Deals, 2012 by Quarter 94
5.6.2 Metabolic Disorders – Deals of the Year 95
5.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2012 97
5.7.1 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, 2012 by Quarter 98
5.7.2 Gastrointestinal – Deals of the Year 99
6 Pharmaceuticals & Healthcare, Deal Summary, By Geography 101
6.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2012 101
6.1.1 Pharmaceuticals & Healthcare, North America Region, Deals, 2012 by Quarter 102
6.1.2 North America – Deals of the Year 103
6.2 Pharmaceuticals & Healthcare, European Region Deals, 2012 106
6.2.1 Pharmaceuticals & Healthcare, Europe, Deals, 2012 by Quarter 107
6.2.2 Europe – Deals of the Year 108
6.3 Pharmaceuticals & Healthcare, Asia-Pacific Region, Deals, 2012 110
6.3.1 Pharmaceuticals & Healthcare, Asia-Pacific Region Deals, 2012 by Quarter 111
6.3.2 Asia-Pacific – Deals of the Year 112
6.4 Pharmaceuticals & Healthcare, Rest of the World (ROW) Deals, 2012 114
6.4.1 Pharmaceuticals & Healthcare, Rest of the World Deals, 2012 by Quarter 115
6.4.2 Rest of the World – Deals of the Year 116
7 Pharmaceuticals & Healthcare, Global, Top Financial Advisors 117
7.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, 2012 117
7.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, 2012 118
8 Further Information 119
8.1 Methodology 119
8.2 About GlobalData 120
8.3 Contact Us 120
8.4 Disclosure information 120
8.5 Disclaimer 120


【レポート販売概要】

■ タイトル:Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends – 2012
■ 英文:Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012
■ 発行日:2013年3月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160699
■ 調査対象地域:グローバル
  • 自動車照明の世界市場:ヘッドランプ、リアランプ、フォグランプ、サイドランプ、インテリアランプ
    About Automotive Lighting Automotive lighting, an indispensable component of automobiles is vital to passenger safety, comfort, and styling. It includes lighting and signaling devices fitted on the exterior and interior of the vehicle. While the primary use of automotive lighting is to provide visibility to the driver, improve vehicle conspicuity and alert the presence and position of the vehicle …
  • 電動駆動装置の世界市場2017-2021:ACドライブ、DCドライブ
    About Electric Drives Electric drives have become necessary for efficient speed and motion control of electric motors. The electric drives are primarily categorized into two types: AC and DC. The current market trends are favorable for AC drives because AC motors are more energy efficient than DC motors and do not have unreliable commutators. So, while the market growth of DC drives remained almos …
  • ランジェリー(女性用下着)通販の世界市場
    About Lingerie Lingerie is a term used for women's innerwear. It originated from the French word “linge” for linen. Though in French the term is used for both male and female undergarments, in English it is solely used for women innerwear. The fabric used for manufacturing lingerie is primarily nylon, satin, silk, polyester, and laces. The term lingerie is predominantly used on behalf of undergarm …
  • 高吸水性高分子(SAP)の世界市場予測(~2024年)
    “The super absorbent polymers market is projected to grow at a CAGR of 7.4% between 2019 and 2024.” The super absorbent polymers market is projected to grow from USD 9.0 billion in 2019 to USD 12.9 billion by 2024, at a CAGR of 7.4%. The increased demand for SAP in applications such as personal hygiene, agriculture, medical, and industrial is expected to drive the growth of the super absorbent pol …
  • 2014年戦略提言:Herpes Markers診断検査市場
    The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for Herpes Simplex I/II and Herpes Type VI testing for the following markets:      …
  • アレルギー免疫療法の世界市場2016-2020
    About the Allergy Immunotherapies Market Immunotherapy, often referred to as desensitization, is the closest thing to a cure for allergic diseases and is an established treatment for severe allergies such as allergic rhinitis and allergic asthma. Its administration includes increasing the doses of allergen extracts over a span of time either through injections or sublingual tablets and drops. Alle …
  • 船舶用潤滑油の世界市場2016-2020
    About the Marine Lubricants Market The functions of marine lubricants on a ship are numerous. Some of the areas of application of marine lubricants onboard a marine vessel includes: • Marine engine cylinder • Ramps and side doors • Lifeboat engines and elevators • Hydraulic systems • Transmission systems and open gears • Bow and stern thrusters • Gas compressors and turbochargers • Rudder and prop …
  • 赤外線エミッターおよびレシーバー世界市場2017-2021:セキュリティ、センサー、検査・測定
    About IR Emitter and Receiver IR emitters and receivers are electronic components that function in the IR range of light. An IR emitter is an LED that emits light in the IR spectrum while an IR receiver is a device that detects and decodes the light emitted from the IR emitter. IR emitters and receivers are used in IR sensors, which find applications in consumer electronics, military and aerospace …
  • CNGコンプレッサの世界市場2016-2020
    About CNG Compressors A compressor is an instrument that is designed to supply air or gas at a higher pressure through compression. There are mainly two types of compressors: positive displacement compressors, and continuous flow compressors. Technavio’s analysts forecast the global CNG compressors market to grow at a CAGR of 4.1% during the period 2016-2020. [Covered in this report] The report co …
  • 生物製剤の世界市場動向・予測2016-2026
    Biological Drugs – Discover Revenue Potentials Now, Benefiting Your Authority Do you want to find how high biological drug sales can go? Visiongain’s new analysis gives you those revenue forecasts to 2026 at overall world market, therapeutic class and national level. For biologics you discover data, opportunities, R&D and sales potentials. Our updated report gives you multilevel revenue prediction …
  • フィールドサービス管理(FSM)ソフトウェアの世界市場2016-2020
    About Field Service Management Software FSM software enables the scheduling, allocating, and dispatching technicians for field work, and remotely locating, tracking, and managing the staff and processes. The high management visibility in field operations allows enterprises to quickly recognize and address revenue-generating opportunities. It also helps in prioritizing the allotted work, matching t …
  • モジュール型UPS(無停電電源装置)の世界市場
    The global modular Uninterruptible Power Supply (UPS) market is expected to reach USD 1,425.2 million in 2015 and is estimated to grow at a Compound Annual Growth Rate (CAGR) of 12.7% during the forecast period of 2015–2020. Asia-Pacific is expected to account for the largest share of the global modular UPS market by 2020. The trend of adoption of this technology in this region is mainly driven by …
  • Rappahannock Electric Cooperative:発電所及びSWOT分析2013
    Rappahannock Electric Cooperative - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - …
  • ゲノミクスの世界市場:ゲノム解析装置、消耗品、シークエンシング、PCR、マイクロアレイ
    The global genomics market is segmented on the basis of product, technology, process, end user, and application. By product, the market is categorized into instruments/systems, consumables, and services. In 2015, the consumables accounted for the larger share of the market and expected to grow at the fastest rate during the forecast period. The genomics market by technology is broadly classified i …
  • 国境警備(ボーダーセキュリティ)の世界市場2016-2026
    The latest report from business intelligence provider visiongain offers comprehensive analysis of the global Border Security market. Visiongain assesses that this market will generate revenues of $17.98 billion in 2016. Now: In November 2015 FLIR Systems acquired DVTEL Inc, a leader in software and hardware technologies for advanced video surveillance. This is an example of the business critical h …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。